EntryPoint Capital’s Colgate-Palmolive CL Stock Holding History

EntryPoint Capital’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-144	Closed	-$11.5K	–	1468
2023 Q4	$11.5K	Buy	+144	New	+$10.8K	0.01%	1140

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

EntryPoint Capital's CL Position: Q1 2024 in Review

EntryPoint Capital sold out of Colgate-Palmolive (CL) in Q1 2024, closing a stake of 144 shares — an estimated $11.5K sold.

EntryPoint Capital first reported a position in CL in Q4 2023 and held it in 1 quarter. The position peaked at $11.5K in Q4 2023. 1,765 funds tracked by Wall St. Rank hold CL as of Q1 2024.

EntryPoint Capital reported no remaining Colgate-Palmolive position as of Q1 2024 after selling out during the quarter.
EntryPoint Capital sold 144 Colgate-Palmolive shares in Q1 2024, an estimated $11.5K.
EntryPoint Capital first reported a position in Colgate-Palmolive in Q4 2023 and held it in 1 quarter.
EntryPoint Capital's Colgate-Palmolive position peaked at $11.5K in Q4 2023.
1,765 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2024.

Based on EntryPoint Capital's 13F filing for Q1 2024, filed 14 May 2024.